Search

Search Results

• The Application of Incretin-Based Pharmacotherapy in the Contemporary Management of Type 2 Diabetes: A Review of the Literature

  Jakub Waszczyński, Wojciech Kulej, Wiktor Biesiada, Piotr Kulej, Justyna Woźniak, Justyna Weronika Kmieć, Anna Mariia Chernysh, Aleksandra Dusińska, Kamila Fuczyło, Karolina Stankević

  57253

  2025-01-22
• Tirzepatide and semaglutide in obesity management and their impact on health-related quality of life – a comparative narrative review

  Weronika Kopniak, Sebastian Konopko, Katarzyna Góra, Wiktoria Wasilewska, Blanka Buszta, Inga Kokuszko, Mateusz Markiewicz

  74311

  2026-08-08
• Beyond Pharmacology: Transitioning Off Incretin-Based Therapies and the Role of Lifestyle Interventions in Weight Maintenance

  Emilia Buzek, Anna Tomaszewska, Marcelina Kaczmarek, Maria Pojawa, Aleksandra Chudzik, Jagoda Prządka, Wioletta Witkowska

  71975

  2026-05-24
• Advances in Obesity Treatment: Current Approaches and Future Perspectives

  Wojciech Wiesław Lachór, Monika Barbara Solarz, Julia Piekarska, Justyna Maria Solarz, Jakub Tomasz Wawrzyńców, Weronika Cyrkler, Jakub Robak, Stanisław Telega, Paweł Bollin, Urszula Szymczak

  60060

  2025-04-14
• Tirzepatide in Sport after Inclusion in the WADA Monitoring Program: An Updated Narrative Review of Body Composition, Muscle Preservation and Potential Performance Implications

  Dominika Kochan-Olszewska, Małgorzata Witaszczyk, Alicja Sołtan, Natalia Wiktorzak, Julia Lipska, Jagoda Prządka, Longin Rudnicki, Jakub Pawlicki, Gracjan Koźma, Paweł Klimas, Justyna Laskus, Bartosz Gawior, Olga Stasiak, Marta Borkowska

  74956

  2026-09-13
• From GLP-1 Agonism to Triple-Receptor Therapy. Narrative Review of Semaglutide, Tirzepatide, and Retatrutide in Obesity Management.

  Jerzy Darmoń, Joanna Makowska, Karolina Domańska, Natalia Piegza, Anna Sieczka, Maria Windyga, Krzysztof Paweł Darmoń, Aleksandra Papuga, Makary Hejduk

  70772

  2026-04-21
• Efficacy and safety of semaglutide and tirzepatide in the therapy of obesity and type 2 diabetes – current state of knowledge

  Julianna Rozalia Chyl, Łukasz Kowalewski, Oliwia Barbara Gutowska, Weronika Nowak, Wiktoria Magdalena Kostuch, Agata Zimon, Maria Aleksandra Styczyńska, Olga Błażowska-Danielska, Martyna Zielnik, Alicja Jurewicz

  74691

  2026-08-23
• The Impact of GLP-1 Receptor Agonists on Body Composition and Musculoskeletal Integrity: A Review of Mechanisms, Protective Strategies, and Clinical Perspectives

  Szymon Domagała, Zuzanna Wiater, Aleksandra Włodarczyk, Karolina Brankowska, Marta Jakubowska, Michał Olejnik, Paulina Tymińska, Piotr Artur Górka, Julia Frączek, Witold Kądziołka

  69771

  2026-03-24
• Tirzepatide - a new drug with great potential in controlling glycemia and body weight

  Magdalena Stabrawa , Filip Prusinowski , Maria Teresa Sarata , Aleksandra Kutaj, Tatyana Savitskaya, Ignacy Hatala, Kiryl Savitski

  69364

  2026-03-06
• Orforglipron as a Small-Molecule GLP-1 Receptor Agonist: A New Era of Incretin-Based Oral Therapy?

  Małgorzata Blecharczyk, Aleksandra Jakimowicz, Zuzanna Zofia Kamińska, Aleksandra Malcher, Martyna Mrozek, Martyna Pacanowska-Trawnicka, Agnieszka Zielińska, Igor Zydlewski

  72512

  2026-05-30